Clinical advances in obsessive-compulsive disorder
a position statement by the International College of Obsessive-Compulsive Spectrum Disorders
release_vqsolvfr5vbehj7yjg7qndgf34
by
Naomi A. Fineberg, Eric Hollander, Stefano Pallanti, Susanne Walitza, Edna Grünblatt, Bernardo Maria Dell'Osso, Umberto Albert, Daniel A. Geller, Vlasios Brakoulias, Y.C. Janardhan Reddy, Shyam Sundar Arumugham, Roseli G. Shavitt (+14 others)
2020 Volume 35, Issue 4, p173-193
Abstract
In this position statement, developed by The International College of Obsessive-Compulsive Spectrum Disorders, a group of international experts responds to recent developments in the evidence-based management of obsessive-compulsive disorder (OCD). The article presents those selected therapeutic advances judged to be of utmost relevance to the treatment of OCD, based on new and emerging evidence from clinical and translational science. Areas covered include refinement in the methods of clinical assessment, the importance of early intervention based on new staging models and the need to provide sustained well-being involving effective relapse prevention. The relative benefits of psychological, pharmacological and somatic treatments are reviewed and novel treatment strategies for difficult to treat OCD, including neurostimulation, as well as new areas for research such as problematic internet use, novel digital interventions, immunological therapies, pharmacogenetics and novel forms of psychotherapy are discussed.
In text/plain
format
Archived Files and Locations
application/pdf 452.8 kB
file_3b47fs2axjet5du3jy5w56lhem
|
uhra.herts.ac.uk (web) web.archive.org (webarchive) |
application/pdf 497.9 kB
file_mf5mxaa5mzae3ainy6ygvtjqii
|
minerva-access.unimelb.edu.au (web) web.archive.org (webarchive) |
access all versions, variants, and formats of this works (eg, pre-prints)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar